The presence of gamma' chain impairs fibrin polymerization

Kathryn C Gersh1, Chandrasekaran Nagaswami, John W Weisel

  • 1Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Thrombosis Research
|January 14, 2009
PubMed

Insights

The presence of fibrinogen gamma' chains alters clot structure by slowing fiber aggregation and creating thinner, non-uniform networks. This impacts fibrin polymerization and may influence cardiovascular risk.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Science

Background:

  • A subset of fibrinogen molecules includes an alternatively spliced variant chain, gamma'.
  • Elevated plasma levels of fibrinogen gamma' have been linked to myocardial infarction and venous thrombosis.
  • Fibrin clot structure is a known factor in cardiovascular risk.

Purpose of the Study:

  • To investigate the impact of the fibrinogen gamma' chain on fibrin clot structure.
  • To understand how gamma' chain incorporation affects fibrin polymerization dynamics and resulting clot morphology.

Main Methods:

  • Expression of three distinct fibrinogen variants (gamma/gamma, gamma/gamma', gamma'/gamma') in Chinese hamster ovary (CHO) cells.
  • Analysis of thrombin-mediated fibrinopeptide release using High-Performance Liquid Chromatography (HPLC).
  • Assessment of fibrin polymerization kinetics via turbidity measurements and clot structure visualization using scanning electron microscopy (SEM).
  • Characterization of post-translational modifications on the gamma' chain using mass spectrometry.

Main Results:

  • Fibrinopeptide A release rates were consistent across all fibrinogen variants.
  • Fibrinopeptide B release was accelerated in the gamma'/gamma' homodimer.
  • Fibrin polymerization exhibited slower turbidity increases and lower final absorbance with gamma'-containing fibrinogens.
  • SEM revealed that gamma'/gamma' fibrin clots comprised very thin fibers, while gamma/gamma' fibers resembled gamma/gamma fibers.
  • Non-uniform fiber networks were observed in gamma'-containing fibrin samples.
  • Mass spectrometry identified heterogeneous N-glycan addition and tyrosine sulfation on the gamma' chain.

Conclusions:

  • The incorporation of gamma' chains into fibrinogen significantly alters fibrin clot structure by impeding lateral aggregation.
  • Gamma'-containing fibrin clots display thinner and less uniform fiber networks compared to those without gamma' chains.
  • These structural modifications, potentially driven by charge-charge repulsion from post-translational modifications on the gamma' chain, may influence the polymerization process and contribute to altered cardiovascular risk.
Abstract

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
Disassembly of Intermediate Filaments01:35

Disassembly of Intermediate Filaments

Intermediate filaments (IFs) do not undergo spontaneous disassembly. Enzymes, kinases, and phosphatases add and remove phosphates from specific sites to regulate their disassembly. The IF concentration in the cytoplasm also regulates the disassembly. If the concentration crosses a threshold, it activates the protein kinases in the vicinity, allowing the phosphorylation of IFs.
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...